Cancer

Identifying Resistant Cancers Earlier

Supported by the MIT-Madrid M+Visión Consortium, Team Tx Response is working on a way to measure the effectiveness of cancer therapies and identify resistant cancers early in treatment.

Monitoring Pancreatic Cancer Treatment

Supported by the Madrid-MIT M+Visión Consortium, Team Albumin is developing novel MRI approaches for pancreatic cancer treatment monitoring through in vivo quantification of tissue albumin.

Personalized Chemotherapy Regimes

Supported by the MIT-Madrid M+Visión Consortium, Team Leuko aims to develop home-based test of white blood cells that enables physicians to personalize chemotherapy and increase cancer survival.